Hemoadsorption Treatment of Patients with Acute Infective Endocarditis during Surgery with Cardiopulmonary Bypass - A Case Series
暂无分享,去创建一个
K. Träger | A. Liebold | J. Hartmann | H. Reinelt | C. Skrabal | T. Datzmann | G. Fischer | Janpeter Schroeder | Daniel Fritzler
[1] C. Falk,et al. Effect of extracorporeal cytokine removal on vascular barrier function in a septic shock patient , 2017, Journal of Intensive Care.
[2] J. Takala,et al. What’s new in surgical treatment of infective endocarditis? , 2016, Intensive Care Medicine.
[3] A. Weymann,et al. Combination of ECMO and cytokine adsorption therapy for severe sepsis with cardiogenic shock and ARDS due to Panton–Valentine leukocidin—positive Staphylococcus aureus pneumonia and H1N1 , 2016, Journal of Artificial Organs.
[4] S. Nseir,et al. Hyperoxemia as a risk factor for ventilator-associated pneumonia , 2016, Critical Care.
[5] A. Spittler,et al. Effect of hemoadsorption during cardiopulmonary bypass surgery – a blinded, randomized, controlled pilot study using a novel adsorbent , 2016, Critical Care.
[6] K. Träger,et al. Treatment of Post-Cardiopulmonary Bypass SIRS by Hemoadsorption: A Case Series , 2016, The International journal of artificial organs.
[7] J. Zamorano,et al. 2015 ESC Guidelines for the management of infective endocarditis. , 2016, Revista española de cardiología.
[8] H. Steltzer,et al. Septic Shock Secondary to β-hemolytic Streptococcus-induced Necrotizing Fasciitis treated with a Novel Cytokine Adsorption Therapy , 2014, The International journal of artificial organs.
[9] A. bstract. Systemic Inflammatory Response Syndrome in Heart Surgery : New possibilities for treatment through the use of a cytokine adsorber during ECC ? , 2014 .
[10] E. Macedo,et al. Timing of renal replacement therapy initiation by AKIN classification system , 2013, Critical Care.
[11] C. Putensen,et al. A multicenter randomized controlled study of an extracorporeal cytokine hemoadsorption device in septic patients , 2013, Critical Care.
[12] Gilles Clermont,et al. Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis. , 2012, Kidney international.
[13] Samer A M Nashef,et al. EuroSCORE II. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[14] P. Audia,et al. In-Vitro Myoglobin Clearance by a Novel Sorbent System , 2009, Artificial cells, blood substitutes, and immobilization biotechnology.
[15] John A Kellum,et al. Effects of hemoadsorption on cytokine removal and short-term survival in septic rats , 2008, Critical care medicine.
[16] John A Kellum,et al. Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-&kgr;B DNA binding, and improves short-term survival in lethal endotoxemia* , 2004, Critical care medicine.
[17] A Haverich,et al. Systemic inflammatory response syndrome after cardiac operations. , 1996, The Annals of thoracic surgery.